Wednesday, August 26 – (MedPage Today) — People who took “gray market” compounded retatrutide, an investigational triple hormone receptor agonist, achieved less weight loss with up to 12 months of

Wednesday, August 26 – A pharmacy asked a Texas federal judge to toss claims brought by Novo Nordisk Inc. accusing the pharmacy of illicitly compounding a lucrative weight-loss drug called

Wednesday, August 26 – (MedPage Today) — In January, Jeff La Marca got a prescription for the popular weight loss drug tirzepatide (Zepbound). But he couldn’t afford the $750 monthly

Wednesday, August 26 – Discussing people’s bodies can be fraught. We asked eating disorder experts how to do so – or not – responsiblyIn the age of Ozempic and people

Wednesday, August 26 – The new Medicare GLP-1 Bridge program promises eligible beneficiaries access to popular weight loss drugs for as little as $50 a month. But for some, having

Tuesday, August 25 – Roche, through its subsidiary Genentech, will gain access to the investigational asset HM17321, which is designed to not only elicit weight loss but also improve lean

Monday, August 24 – For people living with diabetes, managing blood sugar can mean constantly watching the clock, keeping meals and medications on schedule and staying alert to changes in

Saturday, August 22 – The Phase 3 study is evaluating two doses of Novo’s Wegovy pill in people with obesity or overweight in combination with a reduced-calorie diet and increased

Saturday, August 22 – Ozempic may work in the brain in almost the opposite way scientists expected, activating hunger-linked neurons that appear essential for sustaining fat loss. The surprising discovery

Friday, August 21 – (MedPage Today) — GLP-1 Use in IBD

Friday, August 21 – (MedPage Today) — A Chicago man was charged with a scheme to impersonate doctors to obtain unauthorized GLP-1 medications on behalf of individuals who paid him,

Thursday, August 20 – Medicare launched a pilot program that could streamline the process to get GLP-1s, with some seniors paying just $50 a month. But many people with the

Thursday, August 20 – As Eli Lilly and Novo Nordisk race for share, surveys show affordability and prescribing preferences may help decide the winners.

Wednesday, August 19 – (MedPage Today) — Experts suggested that GLP-1 agonists may reduce the effectiveness of birth control pills. (The Hill)
A phase III trial of avexitide, a

Wednesday, August 19 – With a Phase 3 trial showing a reduction of serious and severe hypoglycemic episodes in patients who have undergone weight loss surgery, Amylyx Pharmaceuticals plans to

Saturday, August 15 – GLP-1 receptor agonists and dual agonists have transformed the treatment of obesity and other metabolic diseases, and a new editorial co-authored by Dr. Steven Heymsfield of

Friday, August 14 – Studies show that GLP-1 medications may have positive effects on mental health. Image Credit: Delmaine Donson/Getty

GLP-1 medications are associated with a lower risk of worsening

Friday, August 14 – New research shows that using a GLP-1 before bariatric surgery may not increase weight loss. coldsnowstorm · E+/Getty

A new study found that using GLP-1 medications,

Friday, August 14 – A review titled “Integrating Precision Nutrition with GLP-1 Receptor Agonist Therapy: Mechanisms, Clinical Outcomes, and Pharmacoeconomic Implications” examines the biological mechanisms of nutrition, body composition, gut

Friday, August 14 – (MedPage Today) — Bariatric surgery patients who took GLP-1 medications prior to surgery lost the same amount of weight after 1 year as individuals unexposed to

Friday, August 14 – UK media are reporting that a 19-year-old American college student died in her dorm room last year after taking a GLP-1 weight loss drug. Court papers

Friday, August 14 – Khartis raises oral immunology funds, Neurocrine drug safety concerns, and more biotech news from The Readout

Thursday, August 13 – Ozempic-like drugs appear to weaken more than hunger—they may also reduce cravings for alcohol and other addictive substances. Scientists are increasingly tracing this effect to the

Thursday, August 13 – Beyond the legal action, Eli Lilly is calling on healthcare providers, regulatory authorities, online platforms and even logistics companies to help stem the illegal sale of

Thursday, August 13 – (MedPage Today) — For the first time ever, U.S. News & World Report has released ratings of telehealth platforms offering GLP-1 weight-loss drugs.
The inaugural

Thursday, August 13 – As millions turn to online telehealth platforms to get weight loss drugs, U.S. News and World Report is launching its first-ever official evaluation and ratings of

Wednesday, August 12 – The pharmaceutical company is filing lawsuits against six outlets selling versions of its promising but unapproved weight-loss drug, retatrutide.

Wednesday, August 12 – Recent research has found that the popular GLP-1 medication, Mounjaro, may help lower heart attack risk in people with type 2 diabetes. Galina Zhigalova · Moment/Getty

Wednesday, August 12 – (MedPage Today) — More than 150 deaths possibly linked to injectable weight-loss medications were reported in the U.K., according to government regulators. (The Independent)
Texas

Wednesday, August 12 – (MedPage Today) — GLP-1 drugs, used for type 2 diabetes and weight loss, have been touted for their many benefits, but it’s their side effects that

Wednesday, August 12 – (MedPage Today) — Shanghai-based biotech company HuidaGene Therapeutics disclosed the death of a child 1 year ago in a trial of an investigational gene-editing therapy for

Wednesday, August 12 – Medicare’s new weight loss drug program “risks creating barriers at precisely the moment when confidence in broader GLP‑1 coverage is most needed,” writes Jeffrey Millstein.

Tuesday, August 11 – GLP-1 drugs like Mounjaro may help lower heart attack risk by 33%.

Tuesday, August 11 – For decades, obesity medications produced only modest weight loss. But in recent years, Ozempic and related GLP-1 therapies have transformed the field, enabling sustained weight loss

Tuesday, August 11 – An experimental GLP-1 pill helped people with obesity or overweight lose as much as 12.1% of their body weight in just 36 weeks. Unlike injectable drugs

Tuesday, August 11 – Chrissy Metz joins TODAY’s Jenna Bush Hager and Sheinelle Jones to talk about her journey with GLP-1s and becoming a spokesperson for Ro. She opens up

Monday, August 10 – GLP-1 medications may help lower fragility-related fracture risk in people with type 2 diabetes. OLEKSANDRA TROIAN · Moment/Getty

A new study found that GLP-1 medications may

Sunday, August 9 – A heads-up to anyone on medications like Ozempic, Wegovy, Zepbound and more.View Entire Post ›

Sunday, August 9 – Eli Lilly and Co. fired off a round of lawsuits in Delaware federal court seeking to block generic versions of its tirzepatide weight loss and diabetes

Friday, August 7 – In our series “The Cost of Denial” NBC News’ Liz Kreutz reports on the debate over when and how to cover popular weight loss drugs, especially

Friday, August 7 – A legal dispute between the FDA and Eli Lilly over whether the highly anticipated obesity candidate retatrutide is indeed a biologic has come to a head

Friday, August 7 – Another quarter, another battle on the GLP-1 front. This time, the winner seems to be Eli Lilly and Co., which reported a 48% increase in second-quarter

Friday, August 7 – A Texas federal judge has denied Revive Rx’s bid to end Eli Lilly and Co.’s remaining unfair competition claims over the compounding pharmacy’s sales of allegedly

Thursday, August 6 – Eli Lilly’s shares rose nearly 5% to $1,170 apiece in premarket trading as the company reported $23 billion in revenue for the second quarter. The company’s

Thursday, August 6 – Amgen has discontinued Phase 1 obesity candidate AMG 513, leaving MariTide as its sole weight loss asset. Meanwhile, executives said the company’s late-stage pipeline is largely

Thursday, August 6 – As the use of GLP-1 and other incretin-based medications for obesity continues to grow worldwide, researchers at Marshall University have contributed to an international effort to

Thursday, August 6 – Novo Nordisk’s shares fell 6% on Tuesday afternoon after its second quarter earnings report showed a slight miss for the Wegovy pill vs. consensus.

Wednesday, August 5 – (MedPage Today) — The American Diabetes Association (ADA) asked for patience as its Audit and Governance Committee reviews the incident at this year’s annual meeting —

Wednesday, August 5 – (MedPage Today) — Retatrutide Access Expanded

Wednesday, August 5 – A heads-up to anyone on medications like Ozempic, Wegovy, Zepbound and more.

Tuesday, August 4 – (MedPage Today) — GLP-1 Temporal Hollowing

Tuesday, August 4 – (MedPage Today) — Bariatric surgery has long been considered the gold standard for treating obesity. However, with weight-loss medications like GLP-1 receptor agonists skyrocketing in popularity,

Monday, August 3 – As food becomes less stimulating, GLP-1 users are gravitating toward this instead.View Entire Post ›

Sunday, August 2 – (MedPage Today) — Note that some links may require registration or subscription.
Ahman Green, 49, a four-time NFL Pro Bowl running back and the Green

Friday, July 31 – This is the reality TikTok won’t show you.

Thursday, July 30 – GLP-1 drugs linked to temporary hair loss: Here’s why

Thursday, July 30 – Shareholders allege that Novo Nordisk withheld information about crucial protocol changes in a Phase 3 study of the weight loss drug CagriSema, which led investors to

Wednesday, July 29 – (MedPage Today) — Major Pharmaceuticals issued a nationwide recall of multiple doses of levothyroxine sodium tablets, sold under the Major and Cardinal brands, due to subpotency.

Wednesday, July 29 – GLP-1 medications such as Ozempic have transformed the treatment of type 2 diabetes, helping millions of patients better control their blood sugar while reducing cardiovascular risk

Wednesday, July 29 – Pemvidutide showed a “highly statistically significant” treatment effect in patients with alcohol use disorder. Altimmune is going up against Eli Lilly and newcomer Baseline Therapeutics, among

Wednesday, July 29 – Despite the president’s comments, patients say these medications have been life-changing, and their effectiveness cannot be ignored.

Tuesday, July 28 – Can GLP-1s increase the risk of a rare eye condition?

Tuesday, July 28 – Different varieties and doses of GLP-1 medications can have meaningful differences in how they address heart and metabolic health issues, according to new research led by

Tuesday, July 28 – (MedPage Today) — Note that some links may require registration or subscription.
More healthcare workers in Congo went on strike as confirmed Ebola cases in

Saturday, July 4 – On June 16, 2026, the US Food and Drug Administration (FDA) issued 25 warning letters to various telehealth companies alleging that their websites contained false or

Tuesday, May 19 – Semaglutide for Weight Loss Without Diabetes: What the Approval Covers, What Programs Skip, and What Results Actually Look Like